CADTH formally solicits feedback from stakeholders (health care professionals, patients, drug manufacturers, associations, and other interested parties) on projects and draft reports. We value all feedback and are pleased that it has been helping to shape and improve our work.
When a project is ready for feedback, CADTH will notify interested parties by posting a notice to the Calls for Feedback page and issuing an email to subscribers of the CADTH E-Alert service. Instructions on providing feedback are included with every notification.
Because of operational limitations, we are unable to provide individual responses to stakeholders explaining if and why certain feedback did or did not result in report changes. However, all feedback that we receive is carefully considered by members of CADTH project teams and advisory committees. We thank you in advance for your interest and participation.
If you have any questions about the feedback process, please email email@example.com.
If you are a physician or pharmacist, find out if your feedback can count toward a continuing education credit.
Please note that the process for patient group input is separate from the process for stakeholder feedback. To provide patient group input on a drug submission under review through the Common Drug Review (CDR) or the pan-Canadian Oncology Drug Review (pCODR), visit the Provide Input page.